Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 5/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11514981 | 1.00 | GABRR1 (0.45) | GABRR1CYP1A2BLMACE2LTA4H | |
| SCHEMBL5407249 | 0.89 | GABRR1 (0.54) | GABRR1CYP1A2BLMACE2LTA4H | |
| SCHEMBL5407252 | 0.89 | GABRR1 (0.54) | GABRR1CYP1A2BLMACE2LTA4H | |
| SCHEMBL5586095 | 0.81 | GABRR1 (0.46) | GABRR1CYP1A2BLMACE2TDP1 | |
| SCHEMBL8611204 | 0.81 | GABRR1 (0.46) | GABRR1CYP1A2BLMACE2LTA4H | |
| SCHEMBL8611210 | 0.81 | GABRR1 (0.46) | GABRR1CYP1A2BLMACE2LTA4H | |
| SCHEMBL8665181 | 0.81 | ACE2 (0.47) | GABRR1CYP1A2BLMACE2CNR1 | |
| SCHEMBL5586091 | 0.81 | GABRR1 (0.46) | GABRR1CYP1A2BLMACE2TDP1 | |
| SCHEMBL8665179 | 0.81 | ACE2 (0.47) | GABRR1CYP1A2BLMACE2CNR1 | |
| SCHEMBL5774607 | 0.81 | GABRR1 (0.46) | GABRR1CYP1A2BLMACE2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4169199-A | Precursors for prostaglandin analogue and process for preparing the same | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1979-09-25 | — | — | US | disclosed |